» Articles » PMID: 11793012

Postprandial Blood Glucose As a Risk Factor for Cardiovascular Disease in Type II Diabetes: the Epidemiological Evidence

Overview
Journal Diabetologia
Specialty Endocrinology
Date 2002 Jan 17
PMID 11793012
Citations 106
Authors
Affiliations
Soon will be listed here.
Abstract

That cardiovascular disease occurs more frequently in patients with Type II (non-insulin-dependent) diabetes mellitus has been recognized for a long time. However, the extent to which hyperglycaemia contributes to atherosclerosis and cardiovascular disease is still not clear. Epidemiological studies published in recent years suggest that postprandial blood glucose might be an independent risk factor of cardiovascular disease. The main results of these studies, which are reviewed in this article, are that subjects from the general population with mild to moderate hyperglycaemia, following oral glucose load, but not in the fasting state, showed an increased cardiovascular risk. Furthermore, the post-challenge as well as postprandial glucose concentrations of subjects with Type II diabetes were found to be directly associated to incident cardiovascular disease independently of fasting glucose. Also, the correction of fasting hyperglycaemia or HbA1 c or both, disregarding the specific correction of postprandial hyperglycaemia was not found to significantly reduce the incidence of cardiovascular disease in patients with Type II diabetes. Finally, the strict control of both preprandial and postprandial hyperglycaemia yielded a substantial reduction of cardiovascular disease in Type II diabetes. Trials specifically designed to address this issue are needed to determine whether postprandial hyperglycaemia plays an independent and causative role in cardiovascular disease in patients with Type II diabetes.

Citing Articles

BuZhong YiQi Formula Alleviates Postprandial Hyperglycemia in T2DM Rats by Inhibiting α-Amylase and α-Glucosidase In Vitro and In Vivo.

Zeng X, Wang L, Wang M, Hu Z, Li X, Fei G Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006017 PMC: 11858844. DOI: 10.3390/ph18020201.


Ultrasound-assisted extraction of polyphenols from leaves and their α-glucosidase inhibition.

Li G, Bao C, Zhang H, Bai L Front Nutr. 2025; 12:1542217.

PMID: 39944961 PMC: 11813810. DOI: 10.3389/fnut.2025.1542217.


Acute hyperglycemia induces podocyte apoptosis by monocyte TNF-α release, a process attenuated by vitamin D and GLP-1 receptor agonists.

Zhang R, Oh J, Wice B, Dusso A, Bernal-Mizrachi C J Steroid Biochem Mol Biol. 2025; 247:106676.

PMID: 39818342 PMC: 11859504. DOI: 10.1016/j.jsbmb.2025.106676.


Exploring dihydropyrimidone derivatives as modulators of carbohydrate catabolic enzyme to mitigate diabetes.

Ali S, Mansoor F, Albaayit S, Ali F, Dera A, Shahbaz M Sci Rep. 2024; 14(1):31761.

PMID: 39738505 PMC: 11685467. DOI: 10.1038/s41598-024-82765-1.


Inhibitory Mechanism of Camellianin A against α-Glucosidase: In Vitro and Molecular Simulation Studies.

Jia J, Bai L, Chen Y, Liu B Foods. 2024; 13(17).

PMID: 39272600 PMC: 11394705. DOI: 10.3390/foods13172835.